MP51-14 HYPERCHOLESTEROLEMIA PROMOTES THE PROGRESSION OF BLADDER CANCER IN SEVERAL MICE MODELS.

Lin Yang,Jun Yan,Hongqian Guo
DOI: https://doi.org/10.1097/01.ju.0000556421.87431.e4
2019-01-01
Abstract:You have accessJournal of UrologyBladder Cancer: Basic Research & Pathophysiology I (MP51)1 Apr 2019MP51-14 HYPERCHOLESTEROLEMIA PROMOTES THE PROGRESSION OF BLADDER CANCER IN SEVERAL MICE MODELS. Lin Yang*, Jun Yan, and Hongqian Guo Lin Yang*Lin Yang* More articles by this author , Jun YanJun Yan More articles by this author , and Hongqian GuoHongqian Guo More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000556421.87431.e4AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Hypercholesterolemia was reported to be associated with several cancers, such as prostate cancer, breast cancer and colorectal cancer. Urinary bladder cancer (UBC) is one of the most common urogenital malignancies. Whether hypercholesterolemia plays a role in UBC progression remains unclear. Our objective was to investigate the influence of hypercholesterolemia on UBC progression by several mice models. METHODS: 1) Diet induced hypercholesterolemia model. Nude mice were fed with low fat no cholesterol diet (LFNC) or high fat high cholesterol diet (HFHC) w/o ezetimibe (EZ), which inhibited the absorption of cholesterol. T24 xenografts were injected once model established. Tumor growth, etc were measured. 2) BBN induced in situ bladder cancer model in wildtype mice and LDLR-/- mice. Tumor progression was analyzed. 3) MB49 allografts and tail vessel injected lung metastasis model. Allografts’ growth and lung metastases were measured. RESULTS: 1) Diet induced hypercholesterolemia promoted UBC progression (Figure 1). 2) BBN induced UBC was promoted in LDLR-/- mice, a spontaneous hypercholesterolemia mouse model. UBC in situ progressed much faster in LDLR-/- mice (Figure 2B) with more lymph node and lung metastases (Figure 2C and 2D). Shorter survival curve was found in LDLR-/- mice (Figure 2E). 3) Enhanced progression, metastasis of MB49 injected were found in LDLR-/- mice compared to those in wildtype mice. MB49 allografts’ growth was enhanced in LDLR-/- mice with lung metastases which were not detected in wildtype mice (Figure 3A to 3C). Tail vessel injection induced lung metastasis of MB49 showed that enhanced metastasis ability was detected in LDLR-/- mice (Figure 3D to 3F). CONCLUSIONS: Hypercholesterolemia could promote the progression of UBC, which was confirmed in several mice models. Source of Funding: the National Natural Science Foundation of China (81372168, 81470116, 81672873 and 81572519) Nanjing, China, People’s Republic of© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e728-e729 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Lin Yang* More articles by this author Jun Yan More articles by this author Hongqian Guo More articles by this author Expand All Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?